1. Home
  2. TCBX vs YDES Comparison

TCBX vs YDES Comparison

Compare TCBX & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Third Coast Bancshares Inc.

TCBX

Third Coast Bancshares Inc.

HOLD

Current Price

$36.87

Market Cap

628.8M

Sector

Finance

ML Signal

HOLD

YDES

YD Bio Limited Ordinary Shares

N/A

Current Price

$5.08

Market Cap

543.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
TCBX
YDES
Founded
2008
2013
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
628.8M
543.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
TCBX
YDES
Price
$36.87
$5.08
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$45.00
N/A
AVG Volume (30 Days)
71.2K
16.8K
Earning Date
04-22-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
36.33
N/A
EPS
0.88
N/A
Revenue
N/A
N/A
Revenue This Year
$29.99
N/A
Revenue Next Year
$10.14
N/A
P/E Ratio
$42.21
N/A
Revenue Growth
N/A
N/A
52 Week Low
$29.68
$4.73
52 Week High
$43.84
$25.00

Technical Indicators

Market Signals
Indicator
TCBX
YDES
Relative Strength Index (RSI) 40.36 37.86
Support Level $36.39 $4.73
Resistance Level $38.86 $5.37
Average True Range (ATR) 1.08 0.23
MACD -0.12 0.10
Stochastic Oscillator 23.53 47.95

Price Performance

Historical Comparison
TCBX
YDES

About TCBX Third Coast Bancshares Inc.

Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates twenty branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, one branch in Ballinger, Texas, and one branch in Detroit, Texas. The company operates through one segment, community banking, It generates the majority of its revenue from interest on loans, customer service, and loan fees.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: